Cortisol measurement challenges in managing ectopic Cushing’s syndrome with etomidate

Pauline Brouwers(University of Liège), Caroline Le Goff(University of Liège), Pauline Delannoy(Centre Hospitalier Universitaire de Liège), Patrick Pétrossians(Centre Hospitalier Universitaire de Liège), Etienne Cavalier(University of Liège), Laurence Lousberg(Centre Hospitalier Chrétien)
Clinical Chemistry and Laboratory Medicine (CCLM)
December 11, 2025
10.1515/cclm-2025-1211
Cited by 0

Related Papers

Triple-negative breast cancer: treatment challenges and solutions
|Breast Cancer Targets and Therapy|2016|382
Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies
|Therapeutic Advances in Medical Oncology|2016|40
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer
|Breast Cancer Basic and Clinical Research|2016|12
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
|BMC Cancer|2025|7
Appendiceal neuroendrocrine neoplasms
|Current Opinion in Gastroenterology|2019|4